Maria Khan

Company: Ionis Pharmaceuticals

Job title: Clinical Development Lead for FB-LRX

Seminars:

Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide to Treat AMD-Associated Geographic Atrophy 9:30 am

Assess GOLDEN baseline study characteristics Infer GA growth rates – dependence on size, location and focality Informing future trialsRead more

day: Day Two